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Nuclear transport factor p10/NTF2 functions as a Ran–GDP
dissociation inhibitor (Ran-GDI)
Masami Yamada, Taro Tachibana, Naoko Imamoto and Yoshihiro Yoneda
The cytosolic nuclear transport factor p10/NTF2 is
required for the translocation of karyophilic molecules
through nuclear pores [1–3], and the small GTPase Ran
is a key regulator of protein transport between the
nucleus and cytoplasm [4,5]. It has been reported that
p10/NTF2 interacts directly and specifically with
Ran–GDP but not with Ran–GTP [6]. The precise role(s)
of p10/NTF2 in the Ran GTP/GDP cycle are thus far
unclear, however. In this study, we show that
mammalian p10/NTF2 dramatically inhibits the
dissociation of [3H]GDP from Ran and the binding of
[35S]GTPgS to Ran following the dissociation of non-
radioactive GDP by RCC1, the only known mammalian
guanine nucleotide exchange factor for Ran (Ran-GEF)
[7]. In contrast, the dissociation of [35S]GTPgS from
Ran, which was also catalyzed by RCC1, was not
affected by p10/NTF2. Furthermore, the activities of
wild-type p10/NTF2 and the mutant forms M84T and
D92G in an assay of nuclear protein import in a
digitonin-permeabilized cell-free system correlated with
their level of inhibition of the dissociation of nucleotide
from Ran–GDP. These results suggest that p10/NTF2
acts as a GDP dissociation inhibitor for Ran (Ran-GDI),
thereby coordinating the Ran-dependent reactions that
underlie nuclear protein import. 
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Results and discussion
In order to understand the function of p10/NTF2 in the
Ran–GTP/Ran–GDP cycle, we first examined its effect on
the nucleotide exchange activity of Ran, as catalyzed by
RCC1, a chromatin-associated mammalian GEF for Ran
[7]. The nucleotide exchange activity of Ran was assayed
by measuring the dissociation of [3H]GDP from
Ran–[3H]GDP, or the binding of [35S]GTPγS to Ran–GDP
(see Materials and methods) [8]. As shown in Figure 1a,b,
both the dissociation of [3H]GDP and the binding of
[35S]GTPγS were dramatic and were inhibited by
p10/NTF2 in a dose-dependent manner. But when in the
presence of 0.2% Triton X-100, p10/NTF2 failed to inhibit
the dissociation of [3H]GDP from Ran (data not shown),
suggesting that it has no effect on the non-enzymatic disso-
ciation of GDP from Ran. These results indicate that
p10/NTF2, which exists as a homodimer, specifically
inhibits the RCC1-catalyzed dissociation of GDP from
Ran. Paschal et al. [6] reported that the nucleotide
exchange activity stimulated by RCC1 was not detectably
affected by p10/NTF2, but it is likely that the dose of
recombinant RCC1 used in their study (2.8 µg) was exces-
sive when compared with the amount of Ran–GDP present
(1.2 µg) — the molecular ratio of RCC1 to Ran–GDP was
1.3:1. By contrast, we found that 0.05 pmol RCC1 was suf-
ficient to catalyze the dissociation of GDP from 50 pmol
Ran–GDP; furthermore, when the molecular ratio of RCC1
to Ran–GDP was 1:1000, the percentage of [3H]GDP that
dissociated from Ran–[3H]GDP was 90.1 ± 0.82% (n=3).
But, as Paschal et al. [6] reported, p10/NTF2 did not inhibit
the dissociation of [3H]GDP from Ran–[3H]GDP when the
molecular ratio of RCC1 to Ran–GDP was more than 1:100
(0.5 pmol and 50 pmol, respectively), irrespective of the
preincubation of p10/NTF2 with Ran–[3H]GDP. It would
be interesting to know the molar ratio of RCC1 to
Ran–GDP in vivo, at the site proximal to the nuclear enve-
lope, as it appears likely that this ratio is critical for
p10/NTF2 to function as a Ran-GDI. 
The relative concentrations of Ran, RCC1 and p10/NTF2
within the nucleus and the cytoplasm cannot be estimated
precisely, however, because these proteins probably leak
out of the nucleus during cell fractionation procedures.
We investigated the subcellular localization of p10/NTF2
or Ran in Madin–Darby bovine kidney (MDBK) cells
using immunofluorescence microscopy. Cells incubated
with affinity-purified mouse monoclonal antibodies to
recombinant human p10/NTF2 showed a strong nuclear-
rim staining pattern, along with additional nucleoplasmic
and weak cytoplasmic signals. The staining pattern of cells
incubated with affinity-purified rabbit polyclonal antibod-
ies to recombinant Ran, which were prepared in our labo-
ratory, showed Ran to be located predominantly in the
nucleus, although small amounts were also found in the
cytoplasm (data not shown). It was previously reported
from similar experiments that RCC1 is a chromatin
protein, which binds to DNA and is located exclusively in
the nucleus [9]. Taking these findings together, it is con-
ceivable that the molar ratio of RCC1 to Ran at the
nuclear pores is approximately 1:1000 and that this would
therefore permit p10/NTF2 to exhibit its Ran-GDI activ-
ity upon the translocation step of nuclear protein import.
Moreover, it is possible that cytoplasmic p10/NTF2 may
inhibit the GDP/GTP exchange of Ran in the cytoplasm
which may be catalyzed by newly synthesized RCC1. We
therefore speculate that the Ran-GDI effect of p10/NTF2
observed in our study is relevant to the nuclear transport
step in vivo.
It has been demonstrated that, unlike the nucleotide
exchange factors for other small GTPases, RCC1 catalyzes
the dissociation of both GDP and GTP from Ran in a
dose-dependent manner, and the kinetics of the two reac-
tions are approximately similar [7]. We assessed the speci-
ficity of the inhibitory effect of p10/NTF2 on the
dissociation of nucleotide from Ran. As shown in
Figure 1c, p10/NTF2 completely failed to inhibit the dis-
sociation of [35S]GTPγS from Ran, as catalyzed by recom-
binant RCC1. Furthermore, p10/NTF2 failed to inhibit
the GTPase activity of Ran, which was catalyzed by
0.05 pmol Ran GTPase-activating protein 1 (Ran-GAP1;
Figure 1d). (The percentage of [γ-32P]GTP hydrolysed by
Ran, when the molecular ratio of Ran-GAP1 to Ran–GTP
was 1:1000, was 98.7 ± 0.42%; n=3.) These results indicate
that p10/NTF2, by binding to Ran–GDP, specifically
inhibits the release of GDP from Ran.
It was recently reported that two temperature-sensitive
yeast mutants (ntf2-1 and ntf2-2), which contain single
point mutations in highly conserved amino-acid residues
(methionine to threonine at amino-acid 83 (M83T) in
ntf2-1, and aspartic acid to glycine at amino-acid 91
(D91G) in ntf2-2), showed defects in nuclear protein
import at the non-permissive temperature [10]. From an
analysis of crystal structures of rat NTF2 [11] and the
GDP-bound form of Ran [12], the functional localization of
these point mutations in the p10/NTF2 molecule can be
predicted to be as follows: the M83T residue lies in the
β sheet which forms an interface between the two chains in
each homodimer, and the D91G residue lies in the surface
loop that appears to be involved in Ran binding. To
examine the specific binding of these mutant proteins to
Ran–GDP, two single-point mutant proteins (M84T and
D92G) with corresponding substitution in pp15, a human
homolog of p10/NTF2, were generated by site-directed
mutagenesis and prepared as previously reported [13]. The
M84T mutant bound weakly to Ran–GDP, whereas the
D92G mutant completely failed to bind (Figure 2a). A gel
filtration profile of the M84T mutant after preincubation
for 30 min at 37°C showed that, as does the wild-type
p10/NTF2, the M84T mutant exists in solution as a dimer
(data not shown), which was contrary to our expectation
based on the crystallographic analysis. Judging from these
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The effects of p10/NTF2 on guanine nucleotide binding/dissociation
and on the catalytic activity of Ran. (a) Ran (50pmol), which had been
pre-reacted with [3H]GDP, was incubated with recombinant RCC1
(0.05pmol) in the presence or absence of p10/NTF2. The proportion of
[3H]GDP that dissociated from Ran was calculated by subtracting the
radioactive counts of [3H]GDP bound to Ran (immobilized on
nitrocellulose filters) after the dissociation reaction from that bound
before the reaction. (b) The non-radioactive GDP-bound form of Ran
(50pmol) and [35S]GTPγS were incubated with recombinant RCC1
(0.05pmol). The binding of GTP to Ran was measured by subtracting
the radioactive counts for [35S]GTPγS bound to Ran immobilized on
nitrocellulose filters before the binding reaction from that bound after the
binding reaction. The value obtained in the absence of p10/NTF2 was
defined as 100%. Each point represents the ratio (%) of the value
obtained in the presence of the indicated dose of p10/NTF2 to that
obtained in the absence of p10/NTF2. The calculated amount (pmol) of
p10/NTF2 was based on values for a dimer in solution. The data are
shown as the mean ± standard error (SE) of three independent
experiments. (c) The effect of p10/NTF2 on the dissociation of
[35S]GTPγS from Ran. Ran (50pmol), which had been pre-reacted with
[35S]GTPγS, was incubated with recombinant RCC1 (0.05pmol) in the
presence or absence of p10/NTF2. The proportion of [35S]GTPγS that
dissociated from Ran was calculated as described for [3H]GDP in (a).
The value obtained in the absence of p10/NTF2 is defined as 100%.
Each point represents the ratio (%) of the value obtained in the
presence of the indicated dose of p10/NTF2 to that obtained in the
absence of p10/NTF2. The data are shown as the percent mean ± SE
of three independent experiments. (d) The effect of p10/NTF2 on GTP
hydrolysis by Ran. Ran (50pmol), pre-reacted with [γ-32P]GTP, was
incubated with recombinant Ran-GAP1 (0.05pmol) in the presence or
absence of p10/NTF2. The GTP-hydrolysis activity of Ran was
calculated by subtracting the radioactive counts of [γ-32P]GTP bound to
Ran immobilized on nitrocellulose filters after the hydrolysis reaction
from that bound before the hydrolysis reaction. The value obtained in the
absence of p10/NTF2 is defined as 100%. Each point represents the
ratio (%) of the value obtained in the presence of the indicated dose of
p10/NTF2 to that obtained in the absence of p10/NTF2. The data are
shown as the percent mean ± SE of three independent experiments.
data, the M84T mutant binds to Ran–GDP with low affin-
ity as a dimer. We then performed a [3H]GDP-dissociation
assay at 37°C, which is the non-permissive temperature for
the yeast mutant proteins. The M84T mutant slightly
inhibited the RCC1-catalyzed dissociation of [3H]GDP
from Ran, whereas the D92G mutant was inactive in this
respect (Figure 2b). These results indicate that the Ran-
GDI activities of p10/NTF2 and its mutant forms correlate
with their binding affinities for Ran–GDP.
We next examined the effects of wild-type p10/NTF2 or its
mutant forms on nuclear protein import in a digitonin-per-
meabilized cell-free assay. The wild-type p10/NTF2 (used
at 2 or 10 µg/ml) stimulated protein import in a dose-depen-
dent manner (Figure 3a). Under the same assay conditions,
the M84T mutant, which has a low binding affinity for
Ran–GDP, stimulated protein import slightly (Figure 3b),
whereas the D92G mutant, which lacks the ability to bind
to Ran–GDP, had no effect on protein import (Figure 3c).
The relative activities of p10/NTF2 and its mutant forms in
stimulating nuclear protein import are plotted as a function
of concentration in Figure 3d. These results clearly show
that the activities of p10/NTF2 and its mutant forms in the
cell-free import assay correlate well with both their
Ran–GDP binding affinities and their Ran-GDI activities.
It has been proposed that at least part of the energy
required for the import of substrates via translocation
through the nuclear pore complex is supplied from the
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Figure 2
Interaction between p10/NTF2 (wild-type) or its mutant forms (M84T
and D92G) and Ran–GDP, and their inhibitory effects on Ran-GEF
activities. (a) A binding assay of Ran–GDP to wild-type (WT)
p10/NTF2 or its mutant forms (M84T and D92G) coupled to
cyanogen-bromide–Sepharose beads was performed as previously
reported [21]. The amount of Ran–GDP that bound was detected by
SDS–PAGE followed by staining with Coomassie brilliant blue.
(b) Ran (50 pmol), which had been pre-reacted with [3H]GDP, was
incubated with recombinant RCC1 (0.05 pmol) in the presence or
absence of p10/NTF2 or one of its mutant forms (M84T or D92G).
The proportion of [3H]GDP that dissociated from Ran was calculated
and the value defined as described in Figure 1a. Each point represents
the ratio (%) of the value obtained in the presence of the indicated
dose of p10/NTF2 or its mutants (M84T and D92G) to that obtained in
the absence of p10/NTF2; the data are shown as the percent
mean ± SE of three independent experiments.
p1
0/
N
TF
2(
W
T)
[3
H
]G
D
P
 d
is
so
ci
at
io
n
(%
)
50403020100
0
20
40
60
80
100
(b)(a)
WT (n = 3)
   Current Biology
 M84T (n = 3)
D92G (n = 3)
p10/NTF2 (pmol)
30–
kDa  
20.1–
14.4–
–Ran–GDP
–p10/NTF2s
M
84
T 
m
ut
an
t
D
92
G
 m
ut
an
t

Figure 3
(b)(a) (c) (d)
Negative control
D92G (–)
D92G (10 µg/ml)

Negative control
p10/NTF2 (–)
p10/NTF2 (2 µg/ml)
p10/NTF2 (10 µg/ml)
Negative control
p10/NTF2 (–)
M84T (10 µg/ml)
p10/NTF2 (10 µg/ml)
1086420
0
1.0
1.2
1.4
1.6
1.8
2.0 WT
M84T
D92G
p10/NTF2 (µg/ml)
R
el
at
iv
e 
in
te
ns
ity
 o
f m
ea
n
flu
or
es
ce
nc
e 
ou
tp
ut200
160
120
80
40
0
180
150
120
90
60
30
0
200
160
120
80
40
0
100 101 102
Fluorescence output
103 104 100 101 102
Fluorescence output
Current Biology   
103 104 100 101 102
Fluorescence output
103 104
N
um
be
r o
f c
el
l c
ou
nt
s
N
um
be
r o
f c
el
l c
ou
nt
s
N
um
be
r o
f c
el
l c
ou
nt
s
Activities of p10/NTF2 (wild-type) or its mutants (M84T and D92G) for
supporting protein import in a digitonin-permeabilized cell-free assay
(MDBK cells), as analyzed by flow cytometry. Protein import activity
was monitored by fluorescence-activated cell sorting (FACS) using a
calibur flow cytometer with CELLQUEST data analysis software. The
fluorescence output generated by the flow cytometer when the import
assay was performed with the indicated dose of wild-type p10/NTF2
or its mutant forms (M84T or D92G) is plotted against cell numbers. A
chemical conjugate of allophycocyanin and the synthetic peptide
(CYGGPKKKRKVEDP) containing the nuclear localization signal of
SV40 T-antigen (T-APC) was used as a cargo. (a) Effect of wild-type
p10/NTF2 on protein import in the presence of recombinant mouse
importin-α (40 µg/ml), mouse importin-β (40 µg/ml), Ran–GDP
(10 µg/ml), 1 mM ATP, 5 mM creatine phosphate, 20 U/ml creatine
phosphokinase and 1 mM GTP. The negative control indicates protein
import activity in the presence of T-APC only. (b) Comparison of the
activities supporting protein import of the M84T mutant and wild-type
p10/NTF2 in the presence of the recombinant proteins and energy
systems listed in (a). (c) The effect of D92G on protein import in the
presence of the recombinant proteins and energy systems listed in (a).
(d) The relative activities for supporting protein import of the wild-type
(WT) p10/NTF2, the M84T mutant or the D92G mutant. The relative
intensity of mean fluorescence output obtained in the absence of
p10/NTF2 is defined as 1.0. Each point represents the ratio of the
value obtained in the presence of the indicated dose of p10/NTF2 or
its mutants (M84T or D92G) to that obtained in the absence of
p10/NTF2. The data are shown as the percent mean ± SE of five
independent experiments.
hydrolysis of GTP by Ran [14–16]. But it is generally
thought that the role of Ran in nuclear protein import is not
limited to its GTPase activity. For example, nuclear
Ran–GTP may be involved in terminating protein trans-
location — through the dissociation of the complex made
up of the nuclear localization signal (NLS), substrate and
carrier — by its binding to importin-β. Thus, the Ran–GTP
concentration gradient across the nuclear pore complex
appears to be crucial for nucleocytoplasmic transport;
p10/NTF2 may regulate the cellular ratio of Ran–GDP to
Ran–GTP through its Ran-GDI activity. If an excess of free
Ran–GTP is supplied, in the absence of any controlling
factors, it may bind to the NLS–substrate–carrier complex,
causing the disruption of the complex, prior to the final
stage of transport into the nucleus. Alternatively, given that
the binding affinity of p10/NTF2 for Ran–GDP appears to
parallel its nuclear-import-stimulating activity, p10/NTF2
may increase the efficiency of Ran–GDP function through
their direct interaction, for example by specifically localiz-
ing Ran to the nuclear pore complex [17]. Further experi-
ments are required to elucidate the precise role of
p10/NTF2 in nucleocytoplasmic transport. The results pre-
sented here indicate that p10/NTF2 regulates the action of
RCC1 through an interaction with GDP-bound Ran. We
propose that p10/NTF2 coordinates the Ran-dependent
reactions that underlie nuclear import through its function
as a Ran-GDI. The data provide the first evidence for the
function of p10/NTF2 in the Ran GTP/GDP cycle, which
is essential for nuclear protein import.
Materials and methods
Assays for the binding and dissociation of Ran and nucleotides
Recombinant human p10/NTF2/pp15 [13], Ran [18] and RCC1 [19]
proteins were prepared from E. coli and purified as previously described
[13,18,19]. Ran–[3H]GDP was prepared by incubating the non-radioac-
tive GDP-bound form of Ran (50 pmol) with 4.0 µM [3H]GDP
(3–5 × 103 cpm/pmol; Amersham) for 5 min at 30°C. Recombinant
p10/NTF2 (0–50 pmol) was then added to the solution containing the
[3H]GDP-bound Ran (10 pmol), and the mixture was incubated for 5 min
at 30°C or 37°C. After stably binding Ran–[3H]GDP and p10/NTF2 by
preincubation (the preincubation of Ran–[3H]GDP and p10/NTF2 is
critical for the Ran-GDI activity of p10/NTF2), recombinant RCC1
(0.05 pmol) was added, and the mixture was incubated for a further
5 min at 30°C or 37°C. The radioactivity trapped on nitrocellulose filters
(Schleicher and Schuell) was then counted. To assay for [35S]GTPγS
binding, the non-radioactive GDP-bound form of Ran (50 pmol) and
each dose of recombinant p10/NTF2 (0–50 pmol) was incubated with
0.5 µM[35S]GTPγS (2.5–4 × 103 cpm/pmol; Du Pont) and non-radioac-
tive 4.5µM GTPγS for 5 min at 30°C. The recombinant RCC1
(0.05 pmol) was then added, and the protocol then followed the steps
described for the assay for [3H]GDP dissociation from Ran. The
[35S]GTPγS dissociation assay was also performed as described for the
assay of [3H]GDP dissociation from Ran, except that 1.4 µM
[35S]GTPγS (3–5 × 104 cpm/pmol) was used instead of [3H]GDP. 
Assay for [γ-32P]GTP hydrolysis on Ran
The [γ-32P]GTP-bound form of Ran was prepared by incubating non-
radioactive Ran–GTP (50pmol) with 1.4 µM [γ-32P]GTP
(5 × 103 cpm/pmol; Amersham) and 12.6µM non-radioactive GTP for
5 min at 30°C. Recombinant p10/NTF2 (0–100pmol) was added to
the solution containing Ran–[γ-32P]GTP (10 pmol) and the mixture was
incubated for 5min at 30°C. After the incubation, recombinant Ran-
GAP1 (0.05 pmol) [20] was added, and the protocol then followed the
steps described above for the assay of [3H]GDP dissociation from Ran.
Supplementary material 
Additional methodological detail is published with this paper on the
internet.
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Supplementary materials and methods
Assay for the dissociation of [3H]GDP from Ran
The Ran-GEF activity of recombinant RCC1 was assayed by a rapid fil-
tration method. Recombinant human p10/NTF2/pp15 [S1], Ran [S2]
and RCC1 [S3] proteins were prepared from E. coli and purified as
previously described [S1–S3]. To prepare the [3H]GDP-bound form of
Ran, 5 µl of the non-radioactive GDP-bound form of Ran (50 pmol) in a
solution containing 50 mM Tris-HCl (pH 7.6), 100 mM CH3COOK,
2 mM MgCl2, 1 mM DTT and 0.2% Lubrol was incubated with 4.0 µM
[3H]GDP (3–5 × 103 cpm/pmol; Amersham) in a solution (5 µl) contain-
ing 50 mM Tris-HCl (pH 7.6), 100 mM CH3COOK and 4 mM EDTA for
5 min at 30°C. After the incubation, 0.65 µl of 100 mM MgCl2 was
added and the mixture was immediately cooled on ice for at least 5 min,
to prevent the dissociation of [3H]GDP from Ran. Under these experi-
mental conditions, approximately one-fifth (10 pmol) of the non-radioac-
tive GDP-bound form of Ran (50 pmol) was converted to the
[3H]GDP-bound form. 20 µl of recombinant p10/NTF2 (0–50 pmol) in
75 mM Tris-HCl (pH 7.6), 100 mM CH3COOK, 8 mM MgCl2, 0.5 mM
GTP, 0.5 mM GDP, 1 mg/ml BSA and 1 mM DTT was then added to
the above solution, which contained the [3H]GDP-bound form of Ran,
and the mixture was incubated for 5 min at 30°C or 37°C. After stable
binding between Ran–[3H]GDP and p10/NTF2 was achieved by prein-
cubation (the preincubation of Ran—[3H]GDP and p10/NTF2 is critical
for the Ran-GDI activity of p10/NTF2), 0.5 µl of recombinant RCC1
(0.05 pmol) in 50 mM Tris-HCl (pH 7.6), 100 mM CH3COOK, 2 mM
MgCl2 and 1 mM DTT was added, and the mixture was incubated for a
further 5 min at 30°C or 37°C. 2 µl of ice-cold 20 mM Tris-HCl at
pH 8.0 containing 25 mM MgCl2 and 100 mM NaCl was added to the
reaction mixture, which was then rapidly filtered on nitrocellulose filters
(Schleicher and Schuell). The radioactivity trapped on the filters was
then counted. 
Assay for [35S]GTPγS binding to the GDP-bound form of Ran 
The [35S]GTPγS binding assay was also performed by a rapid filtration
technique. The non-radioactive GDP-bound form of Ran (50 pmol) and
each dose of recombinant p10/NTF2 (0–50 pmol) were incubated with
0.5 µM [35S]GTPγS (2.5–4 × 103 cpm/pmol; Du Pont) and non-
radioactive 4.5 µM GTPγS for 5 min at 30°C in a solution (40 µl) con-
taining 50 mM Tris-HCl (pH 7.6), 3 mM MgCl2, 0.5 mM EDTA, 1 mM
DTT, 0.1% Lubrol and 1 mg/ml BSA. 0.5 µl of the recombinant RCC1
(0.05 pmol) in 50 mM Tris-HCl (pH 7.6), 3 mM MgCl2, 1 mM DTT,
0.2% Lubrol and 1 mg/ml BSA was then added, and the mixture was
incubated for an additional 5 min at 30°C. 2 µl of ice-cold 20 mM Tris-
HCl at pH 8.0 containing 25 mM MgCl2 and 100 mM NaCl was added
to the reaction mixture, which was then rapidly filtered on nitrocellulose
filters. The radioactivity trapped on the filters was then counted.
Assay for the dissociation of [35S]GTPγS from Ran 
The [35S]GTPγS dissociation assay was also performed by the rapid fil-
tration technique described above for the assay for [3H]GDP dissocia-
tion from Ran, except that 1.4 µM [35S]GTPγS (3–5 × 104 cpm/pmol)
was used instead of [3H]GDP. Approximately one-fifth (10 pmol) of the
non-radioactive GTP-bound form of Ran (50 pmol) was replaced to the
[35S]GTPγS-bound form. 
Assay for [γ-32P]GTP hydrolysis on Ran 
The Ran-GAP activity of recombinant Ran-GAP1 was also assayed by
the rapid filtration technique. Recombinant human Ran-GAP1 protein
was prepared from E. coli and purified as previously described [S4]. To
prepare the [γ-32P]GTP-bound form of Ran, 5 µl of the non-radioactive
GTP-bound form of Ran (50 pmol) in a solution containing 50 mM Tris-
HCl (pH 7.6), 100 mM CH3COOK, 2 mM MgCl2, 1 mM DTT and 0.2%
Lubrol was incubated with 1.4 µM [γ-32P]GTP (5 × 103 cpm/pmol;
Amersham) and 12.6 µM non-radioactive GTP in a solution (5 µl) con-
taining 50 mM Tris-HCl (pH 7.6), 100 mM CH3COOK and 4 mM EDTA
for 5 min at 30°C. After the incubation, 0.65 µl of 100 mM MgCl2 was
added and the mixture was immediately cooled on ice for at least 5 min,
to prevent the dissociation of [γ-32P]GTP from Ran or the hydrolysis of
[γ-32P]GTP on Ran. Approximately one-fifth (10 pmol) of the non-
radioactive GTP-bound form of Ran (50 pmol) was converted to the [γ-
32P]GTP-bound form. 20 µl of recombinant p10/NTF2 (0–100 pmol) in
75 mM Tris-HCl (pH 7.6), 100 mM CH3COOK, 8 mM MgCl2, 0.5 mM
GTP, 0.5 mM GDP, 1 mM DTT and 1 mg/ml BSA were added to the
above solution, which contained the [γ-32P]GTP-bound form of Ran,
and the mixture was incubated for 5 min at 30°C. After the incubation,
1.0 µl of recombinant Ran-GAP1 (0.05 pmol) in transport buffer
(20 mM HEPES (pH 7.3), 110 mM CH3COOK, 2 mM MgCl2, 5 M
CH3COONa, 0.5 mM ethylene glycol bis(β-aminoethylether)-N,N,N′,N′-
tetraacetic acid (EGTA), 2 mM DTT) was added, and the mixture was
incubated for an additional 5 min at 30°C. 2 µl of ice-cold 20 mM Tris-
HCl at pH 8.0 containing 25 mM MgCl2 and 100 mM NaCl was added
to the reaction mixture, which was then rapidly filtered on nitrocellulose
filters. The radioactivity trapped on the filters was then counted.
Subcloning and purification of recombinant human p10/NTF2
mutants 
A quick change site-directed mutagenesis kit (Stratagene) was used
for preparing the plasmids of p10/NTF2 mutants (M84T and D92G).
These mutant genes were amplified, using the human p10/NTF2/pp15
(wild-type) gene as a template by the polymerase chain reaction. The
primers used were: 5′-CATCATCAGCACGGTTGTGGGCCAGCT-
TAAGGCGGATGA-3′ and its complement, as primers of the M84T
mutant; 5′-GCATGGTTGTGGGCCAGCTTAAGGCGGGTGAAGAC-
CCCA-3′ and its complement, as primers of the D92G mutant. The
plasmids were introduced into E. coli strain BL21(DE3), and their
recombinant proteins, like the wild-type p10/NTF2, were expressed
and purified as previously reported [S1]. 
Binding assay using CNBr–Sepharose beads 
Proteins (wild-type p10/NTF2 and its mutant forms M84T and D92G
mutant; 500 pmol) were coupled to CNBr–Sepharose beads, as previ-
ously reported [S5]. Protein-coupled beads (10 mg) were stored in
transport buffer containing 0.05% 3-[(3-Cholamidopropyl)-dimethylam-
monio]-1-propane-sulfonate (CHAPS). Ran–GDP (500 pmol) was
added to CNBr beads, coupled with their recombinant proteins, and
incubated for 2 h at 4°C. The beads were then washed extensively with
transport buffer containing 0.05% CHAPS and the bound proteins
were detected by SDS–PAGE followed by staining with Coomassie
brilliant blue. 
Cell-free import assay and FACS analysis 
Madin–Darby bovine kidney (MDBK) cells were cultured in 5% CO2 at
37°C in Dulbecco’s modified Eagle’s minimum essential medium sup-
plemented with 10% bovine calf serum. Recombinant PTAC58 (mouse
importin-α) [S6], PTAC97 (mouse importin-β) [S7], Ran [S2], and
human p10/NTF2/pp15 [S1] proteins were prepared from E. coli and
purified as previously described. Digitonin-permeabilized MDBK cells
were prepared as reported by Adam et al. [S8]. The assay solution
contained 100 µg/ml T-APC in transport buffer containing 1 µg/ml
each of aprotinin, leupeptin and pepstatin). T-APC was prepared by
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chemical conjugation of APC to a synthetic peptide containing the NLS
of SV40 T-antigen (CYGGPKKKRKVEDP), as described previously
[S6]. For the nuclear protein import assay, the incubation was per-
formed at 37°C for 30 min in the absence or presence of 40 µg/ml
PTAC58, 40 µg/ml PTAC97, 10 µg/ml Ran–GDP, 2–10 µg/ml
p10/NTF2 or its mutants (M84T and D92G), 1 mM ATP, 5 mM creatine
phosphate, 20 U/ml creatine phosphokinase and 1 mM GTP. Nuclear
protein import activity was assessed by fluorescence-activated cell
sorting (FACS), using a calibur flow cytometer with CELLQUEST data
analysis software (Beckton Dickinson). 
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